BridgeMD
New treatment option for Transgender Women
Official title Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
ClinicalTrials.gov ID: NCT06202898
What this study is testing
- What it's testing
- The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Aged ≥18 years
- Male at birth
- Identify as a woman/transgender woman
- Should not be consistently using PrEP (less than four doses per week)
- Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more...
You likely can't join if
- Unwilling to adhere to study procedures
- Participation in an HIV vaccine trial
- Have a life-threatening SUD\
- Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective...
- Unable to provide consent
See the full eligibility criteria
- Aged ≥18 years
- Male at birth
- Identify as a woman/transgender woman
- Should not be consistently using PrEP (less than four doses per week)
- Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program
- Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)
- Have a smart phone that can take pictures
- Unwilling to adhere to study procedures
- Participation in an HIV vaccine trial
- Have a life-threatening SUD\
- Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
- Unable to provide consent
The study team makes the final eligibility decision.
Where it's taking place
- Orlando, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orlando, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.